Erin Podolak

Erin Podolak

St. Jude Children's Research Hospital

Erin Podolak is a science writer in the Department of Strategic Communication, Education and Outreach.

POSTS By Erin Podolak

Amar Gajjar, MD., with patient Charlotte and her mother

Reflecting on nearly 40 years of progress against pediatric brain tumors

Posted by Erin Podolak | May 16, 2022

May is Brain Tumor Awareness Month and a good time to learn more about the diverse group of diseases that make up the most common childhood solid tumor.

Learn more
Marta Salek, M.D., at work at the Unicorn Marian Wilemski Clinic in Poland.

Polish roots led Marta Salek, M.D., to a leading role in SAFER Ukraine effort

Posted by Erin Podolak | May 2, 2022

Dr. Marta Salek of St. Jude was in Poland visiting family when Russia invaded Ukraine. She jumped in to help launch the humanitarian effort SAFER Ukraine.

Learn more
Stephen Mack, MD, PhD

Metabolic processes may yield a new therapeutic window for hard-to-treat brain tumors

Posted by Erin Podolak | Apr 22, 2022

In his laboratory at St. Jude, Stephen Mack, PhD, is researching how metabolic and epigenetic pathways might be perturbed to help treat DIPG, a lethal childhood brain tumor.

Learn more
Sima Jeha, MD, and colleagues meet around a table

Lessons from Lebanon: St. Jude Global reacts to war in Ukraine

Posted by Erin Podolak | Mar 30, 2022

Lessons learned from previous global crises inform the St. Jude Global response to childhood cancer patients displaced by the war in Ukraine.

Learn more
posterior fossa

Getting to the bottom of a medulloblastoma mystery

Posted by Erin Podolak | May 26, 2021

Posterior fossa syndrome develops in some children following surgery for the brain tumor medulloblastoma. St. Jude research offers fresh insight into the mysterious syndrome and advice on how to avoid it.

Learn more
Blocking the progression of pre-leukemic disorders

Blocking the progression of pre-leukemic disorders

Posted by Erin Podolak | Feb 25, 2021

Genetic changes in the biology of blood cells can lead them down a path to cancer. This researcher is figuring out how that happens.

Learn more
Why do many promising experimental drugs fail? Data-driven research may hold the answer

Why do many promising experimental drugs fail? Data-driven research may hold the answer

Posted by Erin Podolak | Nov 5, 2020

G-protein-coupled receptors are a popular target for drug therapies. This researcher is finding out why some drugs targeting GPCRs fail.

Learn more
SMARCB1: Genetic ‘canary in a coal mine’ sparks research

SMARCB1: Genetic ‘canary in a coal mine’ sparks research

Posted by Erin Podolak | Oct 15, 2020

Scientist spent more than a decade finding out how this genetic mutation causes different cancers.

Learn more
Unraveling the ambiguity of risk for childhood cancer survivors

Unraveling the ambiguity of risk for childhood cancer survivors

Posted by Erin Podolak | Sep 21, 2020

Clinical specialists are learning this about the future for childhood cancer survivors and how to help them.

Learn more
Bringing Chemistry to Medicine: Experts in transcription therapy and chemical biology share research though St. Jude symposia

Bringing Chemistry to Medicine: Experts in transcription therapy and chemical biology share research though St. Jude symposia

Posted by Erin Podolak | Sep 16, 2020

There are new ways to fight diseases fueled by abnormal transcription and gene regulation. Find out more about it during these two symposia.

Learn more
Load more posts